Clinical Trial Detail

NCT ID NCT03365661
Title QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Masonic Cancer Center, University of Minnesota
Indications

acute myeloid leukemia

Therapies

ALT-803

Age Groups: senior adult

Additional content available in CKB BOOST